Rebecca Lin
Director/Miembro de la Junta en Shanghai Rarestone Health Tech Group Co. Ltd. .
Perfil
Rebecca Lin is currently the Director at Shanghai Rarestone Health Tech Group Co. Ltd.
and the Senior Partner at Eight Roads Capital Advisors (CHINA).
She completed her undergraduate degree at Shenzhen University in 1994 and obtained an MBA from The Wharton School of the University of Pennsylvania in 2000.
Cargos activos de Rebecca Lin
Empresas | Cargo | Inicio |
---|---|---|
Eight Roads Capital Advisors (CHINA) | Inversor de Capital Privado | 01/01/2021 |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Director/Miembro de la Junta | - |
Formación de Rebecca Lin.
Shenzhen University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Eight Roads Capital Advisors (CHINA) | Finance |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Health Technology |
- Bolsa de valores
- Insiders
- Rebecca Lin